Topper Copies

You are the Director of the National Bioethics Commission who is responsible for assessing the ethical feasibility and oversight of a nationwide gene sequencing program. The project named GeneFuture, aims to sequence the DNA of every newborn child and store it in a centralized national database. The objective is to identify genetic predispositions to serious diseases early in life, allowing for preventive treatment and personalized medicine. Over 100,000 babies have already been enrolled in the pilot phase of the program. The government claims that this move is a landmark step in public health advancement. However, collection of newborn genetic data raises significant ethical concerns, particularly around informed consent, which may not fully capture parents' understanding of the long-term risks involved. Once gathered, this sensitive data could be misused for purposes such as surveillance, insurance discrimination, or commercial marketing by third parties. Uncertainty over data ownership-whether it lies with the state, parents, or the individual as they mature-further complicates the issue. The involvement of private tech and pharmaceutical companies heightens fears of commercial exploitation, especially in the absence of clear mechanisms for individuals to withdraw consent or delete their genetic information upon reaching adulthood. (a) What are the ethical issues you perceive in the implementation of the GeneFuture program? (b) Identify the conflicting interests of different stakeholders in this case. (c) What guiding ethical principles would you recommend for implementation of this project? (Answer in 250 words)

Aakash Om Trivedi, AIR 73, 2025

This case highlight the need for "Commerce with Morality" Gandhian principle. Rise in CRISPR Case Biotechnology, India Genome project. raise such concerns.

Ethical Issues

Director of National Bioethics Commission, You

1. Data sharing with commerical companies. Focus on profit 2. lack of informed consent - violation of Due-process 3. Violation of Duty of informing parent

New Born

1. Right to genetic privacy affect 2. Future discrimination by insurance companies

Corporate profit

1. Focus on interest over harm. 2. human as means for money

(b) Conflicting interest of stakeholder

1. Parent vs Director: parent avoid sharing for harm threat vs Director want data for research 2. Parent vs Company: Company want to use data for profit vs parent protect child from future issue 3. Child vs Company: Child interest in not sharing vs company earn money from data. 4. Director vs Company: Director want safeguard for misuse vs company low regulation 5. Director vs Company: Director for +ve benefit to society vs company for selfish interest.

(c) guiding principles for project

1. Consent of parent: as child minor 2. primum non-cera (No harm principle) to child due to data sharing 3. parent awareness of all future concern 4. Guidelines for genetic Data sharing with privates 5. portal for easy delete of genetic information 6. Company restriction of sharing data with Consent of parent, children. 7. Use of Genetic Data: only for public interest 8. Transparent awareness of development 9. Right to forgotten: from National Database 10. Opt out, option for not sharing to companies 11. Awareness in Citizen about Data Right. eg) School Curriculum 12. Program Code of Ethic 13. Portal monitering and cyber security for no leakage.

Thus, Helsinki [?] medical code of ethics should guide us.